glycyl-arginyl-glycyl-aspartyl-serine has been researched along with angiotensin ii in 1 studies
| Studies (glycyl-arginyl-glycyl-aspartyl-serine) | Trials (glycyl-arginyl-glycyl-aspartyl-serine) | Recent Studies (post-2010) (glycyl-arginyl-glycyl-aspartyl-serine) | Studies (angiotensin ii) | Trials (angiotensin ii) | Recent Studies (post-2010) (angiotensin ii) |
|---|---|---|---|---|---|
| 190 | 0 | 42 | 38,152 | 1,089 | 7,413 |
| Protein | Taxonomy | glycyl-arginyl-glycyl-aspartyl-serine (IC50) | angiotensin ii (IC50) |
|---|---|---|---|
| Atrial natriuretic peptide receptor 3 | Homo sapiens (human) | 0.002 | |
| Type-1A angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.002 | |
| Type-1B angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0018 | |
| Type-1 angiotensin II receptor | Homo sapiens (human) | 0.0055 | |
| Type-2 angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.004 | |
| Type-2 angiotensin II receptor | Homo sapiens (human) | 0.0011 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernillon, J; Louis, D; Wallach, JM | 1 |
1 other study(ies) available for glycyl-arginyl-glycyl-aspartyl-serine and angiotensin ii
| Article | Year |
|---|---|
Specificity of Pseudomonas aeruginosa serralysin revisited, using biologically active peptides as substrates.
Topics: Angiotensin I; Angiotensin II; Arginine; Bacterial Proteins; Endopeptidases; Fibrin Fibrinogen Degradation Products; Hydrolysis; Kinetics; Mass Spectrometry; Metalloendopeptidases; Oligopeptides; Peptide Fragments; Pseudomonas aeruginosa; Substance P; Substrate Specificity | 1998 |